Abstract
In 11 patients with severe angina pectoris a new beta-blocking drug, atenolol (Tenormin; I.C.I.66082), was found in a double-blind randomized trial to reduce significantly the frequency of anginal attacks (P less than 0-001) and the amount of trinitrin consumed (P less than 0-03) in comparison with practolol and placebo. There was no significant improvement in the patients' ability to exercise on the bicycle ergometer.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aström H., Vallin H. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Br Heart J. 1974 Dec;36(12):1194–1200. doi: 10.1136/hrt.36.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillam P. M., Prichard B. N. Propranolol in the therapy of angina pectoris. Am J Cardiol. 1966 Sep;18(3):366–369. doi: 10.1016/0002-9149(66)90055-5. [DOI] [PubMed] [Google Scholar]
- Hamer J., Sowton E. Cardiac output after beta-adrenergic blockade in ischaemic heart disease. Br Heart J. 1965 Nov;27(6):892–895. doi: 10.1136/hrt.27.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KEELAN P. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS. Br Med J. 1965 Apr 3;1(5439):897–898. doi: 10.1136/bmj.1.5439.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
- Wilson D. F., Turner A. S. Trasicor (39,089/Ba) in angina pectoris. A single-blind trial. N Z Med J. 1968 Mar;67(430):406–407. [PubMed] [Google Scholar]